BlueTree Allied Angels

BlueTree Allied Angels is a regional group of accredited investors who invest in regional early-stage companies. This members-only organization is designed to operate as a network of private equity investors who meet on a monthly basis to evaluate and consider pre-institutional, early-stage investments.

Catherine Mott

CEO / Founder

36 past transactions

CytoAgents

Series A in 2023
CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation also known as cytokine storm.

OndeCare

Pre Seed Round in 2022
OndeCare is the premium in-home care marketplace for all ages & schedules; and the employee benefit SaaS solution with full ROI visibility.

C360 Technologies

Venture Round in 2022
C360 Technologies is a video technology that delivers quality non-stitched immersive video products to date. C360 is a different kind of 360/VR company. Unlike most, they don’t stitch or require multi-headed cameras to deliver our stunning 6K immersive broadcast and streaming video. They've worked in the industry since 2008 pioneering original 360 technologies that continue to deliver the highest quality, non-stitched immersive video in the world. Their live output for linear broadcast and OTT streaming platforms coupled with the industry's smallest pro-grade immersive camera is unique compared to others. C360 delivers multiple HD-SDI outputs directly to the broadcast backhaul for live television events while simultaneously delivering a 4K stream to the OTT platform for distribution across VR and second screen (magic screen) applications. Unlimited users are now empowered to independently control their camera location and P/T/Z during the live event. The company was founded in 2008 and is headquartered in Wexford, Pennsylvania.

Augment Therapy

Seed Round in 2021
Augment Therapy is an interactive software that uses the medium of AR to provide virtual pediatric rehab and remote patient monitoring. The company is designed by a pediatric physical therapist, Augment Therapy is an all-in-one solution to engage, motivate, and monitor kids needing therapeutic exercise.

OndeCare

Pre Seed Round in 2021
OndeCare is the premium in-home care marketplace for all ages & schedules; and the employee benefit SaaS solution with full ROI visibility.

Edge Case Research

Series A in 2021
Edge Case is the trusted risk-management partner for companies building self-driving trucks, autonomous robotaxis, and smarter passenger cars. We help developers and operators measure, manage, and insure the risks posed by software driving in the real world. Our mission is to deliver the promise of safe autonomous mobility. It was founded in 2013 and headquartered in Pittsburgh, Pennsylvania.

Gridwise

Seed Round in 2020
The Gridwise app is the leading business platform for gig economy drivers, helping them maximize their earnings and track their business performance all in one place. Their app empowers 100s of thousands of all US gig drivers to run their businesses with unique demand insights, earnings, and activity tracking, performance reporting, and a marketplace of gig worker benefits.

Lindy Biosciences

Series A in 2019
Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.​

Edge Case Research

Seed Round in 2019
Edge Case is the trusted risk-management partner for companies building self-driving trucks, autonomous robotaxis, and smarter passenger cars. We help developers and operators measure, manage, and insure the risks posed by software driving in the real world. Our mission is to deliver the promise of safe autonomous mobility. It was founded in 2013 and headquartered in Pittsburgh, Pennsylvania.

Aeronics

Seed Round in 2018
Aeronics is a technology company that is changing the way they store oxygen, so they can all breathe a little easier. Aeronics have two product offerings right now: Everyday Oxygen and Pawprint Oxygen. Their FDA approved device is launching in 2020.

BoardBookit

Series A in 2018
BoardBookit is a boardroom empowerment platform designed to transform the way companies plan, create and manage board meetings AND the way board members experience them.

Cocomama

Angel Round in 2018
Cocomama is a women-owned business that manufactures delicious baking and hot cocoa mixes. It crafts organic cocoa products, cocoa powders, baking mixes, and brownie thins are used to produce cakes, pastries, and cookies with ingredients sourced from countries like the Dominican Republic, Madagascar, and Indonesia, providing customers with tasty chocolate products.

PittMoss

Convertible Note in 2017
PittMoss produces recycled peat-free potting mixtures for both indoor and outdoor plants. Its products are the result of decades-long research into the use of recycled paper fibers.

C360 Technologies

Series A in 2017
C360 Technologies is a video technology that delivers quality non-stitched immersive video products to date. C360 is a different kind of 360/VR company. Unlike most, they don’t stitch or require multi-headed cameras to deliver our stunning 6K immersive broadcast and streaming video. They've worked in the industry since 2008 pioneering original 360 technologies that continue to deliver the highest quality, non-stitched immersive video in the world. Their live output for linear broadcast and OTT streaming platforms coupled with the industry's smallest pro-grade immersive camera is unique compared to others. C360 delivers multiple HD-SDI outputs directly to the broadcast backhaul for live television events while simultaneously delivering a 4K stream to the OTT platform for distribution across VR and second screen (magic screen) applications. Unlimited users are now empowered to independently control their camera location and P/T/Z during the live event. The company was founded in 2008 and is headquartered in Wexford, Pennsylvania.

Carmell Cosmetics

Series B in 2017
Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repaired tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).

Zive

Seed Round in 2017
Zive is an enterprise software company focused on creating productivity applications for the business and professional user. Its first product, Kiwi for Gmail, transforms Google’s Workspace office suite into a suite of desktop applications with enhanced business integration and productivity features. Kiwi has broad adoption by users in 600+ of the largest enterprise and SMB companies using Google Workspace. In addition to Kiwi for Gmail, Zive is continuing to develop new productivity applications for enterprise users.

ANGLR

Seed Round in 2016
Anglr is a vertical social app and connected device company focused on the $50B sportfishing industry. The centerpiece of the Anglr ecosystem is its best-in-class, on-water fishing app that, enhanced by a connected suite of award-winning IoT devices, enables users to turn their iPhone or Android into a sophisticated digital logbook and social network that records an angler’s most important fishing stats and memories. Once off the water, anglers can “dive deep” into their stats to reminisce, improve, brag, scroll through photos, give fist-bumps, prepare for their next fishing adventure, and more. Check out the ANGLR app at www.anglr.com …… Fishing is fun. ANGLR makes it funner!

RendrFX

Seed Round in 2016
RendrFX is a SaaS-based online plug and play motion graphics messaging maker empowering businesses and individuals to create professional, affordable videos by leveraging video designs curated from its global artist community. Its platform uses online plug and play motion graphics messaging maker by leveraging video designs curated from global artist communities that enable businesses and individuals to create videos with ease and affordability, advertising, and marketing agencies to scale their clients' online video presence and creating a new, fair community for motion graphics artists to sell their work.

Cognition Therapeutics

Series B in 2015
Cognition Therapeutics, Inc. is focused on the discovery and development of small molecule therapeutics targeting the toxic proteins that cause the cognitive decline associated with Alzheimer's disease and other degenerative diseases of the human brain. Toxic proteins play a crucial role in a large class of disease targets, and there are currently no therapeutics available to prevent toxic protein accumulation or block their destructive effects. Cognition is founded on the unique combination of biological expertise around these targets, including proprietary assays that emphasize functional responses and proprietary medicinal chemistry that insures novel, high quality small-molecule drug candidates.

PittMoss

Seed Round in 2015
PittMoss produces recycled peat-free potting mixtures for both indoor and outdoor plants. Its products are the result of decades-long research into the use of recycled paper fibers.

Rinovum Women's Health

Series C in 2014
Rinovum Women's Health, Inc. develops medical devices for women. It offers Stork, a medical device that aids in natural fertility and conception in the privacy of home.
Wombat Security provides information security awareness and training software to help organizations teach their employees to secure behavior. Its Security Education Platform includes integrated knowledge assessments, a library of simulated attacks, and interactive training modules, which have been proven to reduce successful phishing attacks and malware infections by up to 90%.

Carmell Cosmetics

Series A in 2014
Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repaired tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).

Gemmus Pharma

Series B in 2014
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.

Neuros Medical

Series B in 2014
Neuros Medical is a neuromodulation company, is focused on developing proprietary therapies for the unmet needs of patients worldwide. The Company's patented platform technology, Electrical Nerve Block, is focused on the elimination of chronic pain in a variety of applications including neuroma/residual limb pain, chronic post-surgical pain, and chronic migraine.

ALung Technologies

Series B in 2013
ALung Technologies is a medical device manufacturing company that develops intracorporeal and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its technology utilizes Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placed within the central venous bloodstream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein. The company was founded in 1997 and headquartered in Pittsburgh, Pennsylvania.

Physcient

Series A in 2013
Physcient develops modern technology for hand-held surgical instruments that enable speedy recovery without changing surgical procedures. It was founded in 2007 by three scientists/executives with over 75 years of experience developing new technologies for the life and health sciences.

Cryothermic Systems

Venture Round in 2012
Cryothermic Systems (formerly Life Core Technologies) is an American medical device firm that develops a series of products to improve patient outcomes by preventing brain damage. Its product Excel Cryo is a device that lowers the temperature of the brain, which can be applied immediately at the onset of neurologic injury.

Gemmus Pharma

Series A in 2012
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus' lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.

Voci Technologies

Venture Round in 2012
Voci helps companies analyze their audio for the in-depth voice of the customer insights and track call center performance metrics using the most accurate speech recognition, natural language, and machine learning technologies. Companies in highly regulated industries rely on Voci to safeguard their audio and monitor call center agents for compliance purposes. Voci also produces highly readable automatic speech-to-text voicemail output for telecommunication companies and their customers.

Carmell Cosmetics

Series A in 2011
Carmell was founded in 2007 to commercialize technology developed jointly at Carnegie Mellon University and Allegheny General Hospital. The proprietary technology enables the manufacture of biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. These plastics are sterile, off-the-shelf, easy to handle, shape and suture, have controlled degradation rates, contain known levels of bioactivity, and exhibit mechanical properties designed to match the repaired tissue. Carmell's plastics can be simply viewed as plastic forms of ultra-concentrated blood clots; they therefore represent the ideal biomaterials, using the body's own growth and regenerative factors to naturally promote tissue healing. The Company is focused on the sports medicine market, with products designed to accelerate healing and produce better clinical outcomes in treating injuries to connective tissue (e.g., tendons, ligaments and cartilage).

Voci Technologies

Venture Round in 2010
Voci helps companies analyze their audio for the in-depth voice of the customer insights and track call center performance metrics using the most accurate speech recognition, natural language, and machine learning technologies. Companies in highly regulated industries rely on Voci to safeguard their audio and monitor call center agents for compliance purposes. Voci also produces highly readable automatic speech-to-text voicemail output for telecommunication companies and their customers.

DiaKine Therapeutics

Seed Round in 2008
DiaKine Therapeutics, Inc. is a development stage company commercializing novel immune modulators for the treatment of diabetes and related complications. These drugs have the potential to stop the progression of diabetes and reverse damage already caused by the disease. Therapeutics under development by DiaKine include: adjunct therapy to islet cell transplants (in Phase 2 clinical trial), halting the progression of type 1 diabetes in newly diagnosed adults, treatment and prevention of Latent Autoimmune Diabetes of Adults (LADA), treatment and prevention of insulin requiring type 2 diabetic, treatment and prevention of diabetes complications. DiaKine would like to thank the National Institute of Diabetes & Digestive & Kidney Diseases/National Institutes of Health (NIDDK/NIH) for producing the clinical trials supplies for the trial.

TalkShoe

Angel Round in 2008
TalkShoe, Inc. is a platform that facilitates user-generated live and recorded voice and audio content, enabling individuals to create, join, and listen to live group calls, discussions, and interactive podcasts. Founded in 2005 and based in Wexford, Pennsylvania, TalkShoe allows users to engage in voice and text chats on a wide array of topics, including business, sports, politics, and more. The service connects nearly 100,000 users and reaches millions of listeners through recorded Community Calls available on platforms like iTunes. Additionally, TalkShoe offers integration with various social networks, making it easy for users to promote their audio content. As of May 2016, TalkShoe operates as a subsidiary of iotum inc., focusing on providing tools for online creators, including podcast hosting and analytics.

StageMark

Series B in 2007
StageMark develops and markets inflammatory diseases identification and monitoring solutions. The company's product, CB-CAPs, enables user to analyze complement products bound to various blood cell types such as erythrocytes, platelets, reticulocytes, and lymphocytes. StageMark, Inc. was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.

NewCare Solutions

Venture Round in 2005
The SilentAlert Resident Attendant System is a product of NewCare Solutions, LLC. Located in the Pittsburgh metropolitan area, NewCare Solutions is a spinoff of medSage Technologies, LLC and was created when its founder, William Kaigler, was unable to find an effective and affordable solution to help his 85-year old mother live independently in her home. The SilentAlert Resident Attendant System became a reality after his mother was hospitalized and her sleep was continuously disrupted by an audible bed alarm for another patient.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.